Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
Candel Therapeutics (CADL) Ownership Overview
21.00% Insiders
4.34% Mutual Funds
19.59% Other Institutional Investors
5.44% ETFs
49.63% Public Companies and
Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 29.36% of the company’s stock is owned by Institutional Investors, 21.00% is owned by Insiders, and 49.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 17, 2025 | xxxxxxxxxxxxx | $97715 | |
| Jan 17, 2025 | xxxxxxxxxxxxx | $75290 | |
| Jan 17, 2025 | Paul Peter Tak Ceo,director | xxxxxxxxxxxxx | $156703 |
| Jan 17, 2025 | xxxxxxxxxxxxx | $103405 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $25883612 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,431,832 | Insider | 9.96% | 39,133,077 | |
| 4,127,158 | Insider | 9.28% | 36,442,805 | |
| 2,981,983 | Institution | 6.70% | 26,330,910 | |
| 1,418,485 | Institution | 3.19% | 12,525,223 | |
| 1,129,501 | Institution | 2.54% | 9,973,494 | |
| 807,892 | Institution | 1.82% | 7,133,686 | |
| 251,912 | Insider | 0.57% | 2,224,383 | |
| 221,219 | Institution | 0.50% | 1,953,364 | |
| 190,215 | Institution | 0.43% | 1,679,598 | |
| 152,000 | Insider | 0.34% | 1,342,160 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,129,501 | Institution | 2.54% | 9,973,494 | |
| 221,219 | Institution | 0.50% | 1,953,364 | |
| 190,215 | Institution | 0.43% | 1,679,598 | |
| 113,268 | Institution | 0.25% | 1,000,156 | |
| 74,895 | Institution | 0.17% | 661,323 | |
| 66,217 | Institution | 0.15% | 584,696 | |
| 46,777 | Institution | 0.11% | 413,041 | |
| 17,160 | Institution | 0.04% | 151,523 | |
| 14,245 | Institution | 0.03% | 125,783 | |
| 10,305 | Institution | 0.02% | 90,993 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 866,650 | Institution | 1.83% | 7,778,184 | |
| 569,170 | Institution | 1.20% | 5,025,771 | |
| 300,020 | Institution | 0.64% | 2,692,680 | |
| 189,067 | Institution | 0.40% | 1,669,462 | |
| 131,789 | Institution | 0.28% | 1,055,630 | |
| 98,500 | Institution | 0.21% | 884,038 | |
| 94,240 | Institution | 0.20% | 748,266 | |
| 47,769 | Institution | 0.10% | 421,800 | |
| 19,899 | Institution | 0.04% | 178,594 | |
| 12,473 | Institution | 0.03% | 99,036 |
FAQ
Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 19.59% of the company's stock is held by institutional investors, 21.00% is held by insiders, and 49.63% is held by retail investors.
What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.59% of Candel Therapeutics (CADL) stock is held by institutional investors.
What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.63% of Candel Therapeutics (CADL) stock is held by retail investors.
Who owns the most shares of Candel Therapeutics (CADL)?
Estuardo Aguilar-Cordova owns the most shares of Candel Therapeutics (CADL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.